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difference / 3mm distance to agreement) was used to evaluate the 
difference between the measured and calculated dose distribution of 
the test plans. The threshold dose selected for gamma analysis was 10 
% of the maximum dose. Absolute point dose measurements using 
0.057 cc ionisation chamber (A1SL, Standard Imaging Inc, Middleton, 
WI) placed at the centre of the ArcCHECK with PMMA insert were also 
done for all the clinical and test plans and compared with 
TomoTherapy treatment planning system (TPS) calculation. Inter- and 
intra-fractional consistency of the ArcCHECK measurements was also 
investigated by repeated measurements. 
Results: All absolute point dose measurements showed good 
agreement with TPS calculation and the differences were all within ± 
3%. For clinical Helical TomoTherapy plans, ArcCHECK measurements 
showed excellent results for plans using 2.5 and 5cm beam width, 
with average passing rate of 99.2 and 97.2 %, respectively. The 
average passing rate for clinical plans with 1cm beam width was 82.6 
%. The passing rates of test plans with small cylindrical target of 3cm 
diameter using 1 and 2.5cm beam width were 64.8 and 76.2 % 
respectively. This showed that beam width was not the contributing 
factor for the low passing rate. However, the passing rates of plans 
with cylindrical target of 3 and 8 cm diameter using 1cm beam width 
were 64.8 and 99.1 % respectively. And the analysis of dose profiles 
indicated that measurement resolution was a limiting factor in QA 
measurements of Helical TomoTheapy plans with small target 
dimension in the transverse plane. Excellent inter- and intra-
fractional consistency was found, with average passing rates of 98.5 ± 
0.2 and 97.2 ± 0.1 % respectively. 
Conclusions: ArcCHECK is an efficient and reliable tool for pre-
treatment dosimetric verification of Helical TomoTherapy plans. With 
the use of ArcCHECK, absolute dose comparison can be performed 
with passing rate above 90% using gamma analysis with criteria of 3% / 
3mm. However, attention should be paid when measuring targets with 
small dimensions in transverse plane.  
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Purpose/Objective: LINAC-based radiosurgery is commonly used for 
trigeminal neuralgia treatment. Due to the small size and spherical or 
elliptical geometry of the target, small cones are suitable for this 
technique. Because of the small fields involved in this technique, a 
special care was taken in the measurements and the subsequent 
corrections. 
Materials and Methods: A radiosurgery cone set (Brainlab) of 
diameter 5, 6, 7.5 and 10 mm was modelled for a 6MV linac PRIMUS 
(Siemens). Reference dose was measured using a camera PTW Farmer 
type 30013. Output factor, PDDs and OARs were measured for each 
cone in a PTW water phantom MP3 using a diode detector PTW 60012. 
It was necessary to make a correction in output factors ,because diode 
overestimates response in small fields [1]. Correction is up to6% for 
the cone of 5mm. For commissioning the TPS, a set of verifications 
was performed: accuracy of monitor units calculations, isocentre 
localization, punctual dose with MOSFET, and dose profiles with 
Gafchromics films.  
Results: Output factors are shown in the table. 
 
 
After modelling, we performed several verifications: 
1) Accuracy of monitor unit calculations for several SSD and depths. 
Manual calculation of monitor units performed with measured data 
shows a maximum difference of 1.3%. 
2) Isocentre verification.We used a radiochromic film (Gafchromic 
EBT2) placed in the stereotactic localizer with a pin to locate 
isocentre. After a CT scan was made, pin delineated and used like 
isocentre to deliver the treatment. Isocentre localization was less 
than 0.5mm. (Fig1). 
3) For dose verification we scanned an anthropomorphic Alderson 
Rando phantom head (Fig.2) with a MOSFET detector placed inside. 
We localized the CT scan using iPLan, marked the isocentre at the 
MOSFET and delivered treatment. The dose agreement was for the 10-
mm cone, lesser than 5% (MOSFET uncertainty: 3%). For smaller cones, 
the dose gradient makes very difficult the positioning of the MOSFET, 
hence difference between planned dose and measured dose increases. 
4) Verification with gafchromic EBT2. A film wasplaced at depth of 15 
mm in a water phantom and an arc of 120° was delivered. We 
compared measured datawith TPS calculation using OmniPro® (IBA). A 
good agreement is showed for inplane and crossplane 
comparisons.(Fig3) 
 
  
Conclusions: Due to the difficulty for measuring small fields we 
performed several verifications using different measurement methods 
to commission the modelling of Brainlab cones for trigeminal neuralgia 
in iPlan. The most accurate and reliable method for measuring 
relative dose is Gafchromics films, because it have the best 
resolution. Diodes and MOSFET can be used for output factor 
measurements, but corrections must be taken into account. Results 
are consistent and the first clinical results indicate a favourable 
evolution. 
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Purpose/Objective: Radiochromic EBT3 films are gaining acceptance 
as a valuable dosimetry system. The advantages of these films over 
other dosimetry systems are a low spectral sensitivity, high spatial 
resolution and ease of use. The feasibility to use these EBT3 
GafChromic (GC) films for absolute and relative dosimetry of a 50 kV 
contact therapy system was evaluated. 
Materials and Methods: The half-value layer (HVL) was determined 
for a 3 cm diameter circular applicator usinga soft X-ray parallel-plate 
chamber PTW N23342 (PTW, Freiburg, Germany) based on in-air 
measurement. The HVL of the system is necessary to obtain factors 
converting air-kerma measurements into water-kerma. The absorbed 
dose to water at the surface was determined using the in-air 
calibration method. EBT3 GC films were calibrated at 5 mm depth in a 
solid water phantom (dose range 0-5,5 Gy). The films were scanned 
24h after irradiation with the Epson Expression 10000 XL. Scanvalues 
were acquired using the green and red color channel and converted 
into optical density (OD). These OD were plotted against the dose 
obtained from the ionization chamber to get the calibration curves. 
To acquire the PDD curves, EBT3 films were irradiated in a solid water 
phantom perpendicular or parallel to the beam axis. The films were 
scanned 24h after irradiation and scanvalues were determined for the 
green and red color channel. After conversion of the scanvalues to 
OD, the dose was calculated and the PDD's were plotted.To analyze 
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the feasibility of the EBT3, a comparison was made with the PDD 
determined by means of the ionization chamber. For this purpose, the 
chamber was irradiated at different depths in the solid water 
phantom (range between 0 mm and 30 mm). 
Results: A HVL of 0,87 mm Aluminium (Al) was obtained for the 3cm 
applicator. The in-air measurements with the ionization chamber 
provide an absorbed dose to water at the surface of 0,92 Gy/min. The 
calibration curves for the EBT3 GC film in the green and red color 
channel is presented in figure 1 (top). The best fit between the 
optical density and dose is a fifth degree polynomial fit. The PDD 
curves obtained with the ionization chamber and EBT3 are shown in 
figure 1 (middle and bottom). The curves are normalized to the 
surface (0 mm) and show a very rapid dose fall-off with depth. Films 
exposed parallel to the beam axis show good agreement with the 
ionization chamber between 4 mm and 13mm. At the surface, EBT3 
has lower doses and at depths beyond 13 mm the GC film has a higher 
response compared with the ionization chamber measurements. Films 
exposed perpendicular to the beam axis give higher doses in 
comparison with the ionization chamber over the whole range of 
depths, except for 10 mm depth. Although, all measuring points 
(parallel and perpendicular) agreed within 5% beyond 3 mm depth.  
  
Conclusions: Good agreement (max 5% difference) was found between 
ionization chamber and EBT3 GC film. This study showed that EBT3 GC 
film is a feasible option for absolute and relative dosimetry of a 50 kV 
X-ray system. Furthermore,the film can be exposed parallel and 
perpendicular to the beam axis. 
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Purpose/Objective: Each treatment plan which use dynamic methods 
for inpatient dose distribution is routinely verified before first 
treatment session. Unfortunately, this pre-treatment method is not 
fully sufficient in terms of necessary information for physicians of 
correct daily dose delivery. The aim of this study was to analyze the 
behavior of the new in-vivo dosimetric device DAVID (PTW Freiburg, 
Germany) in accordance to the calibrations factors of the device. 
Materials and Methods: The advanced device is designed for each 
specific accelerator and depend on number of leafs installed in MLC. 
It consists of very thin translucent multi-wires ionization chambers 
which are parallel to the leaf direction of movement. It is attached to 
the collimator of the gantry for all treatment fields. After some 
clinical implementation tests it was observed that not all errors could 
be easily explained. During the study the frequency of calibration 
process was evaluated. The default period time is set to 8 hours. The 
calibration was performed each 0.5 hour, then each 2 hours, once per 
day and only once per week. For each group the calibration was 
performed 10 times for all 80 chambers. The reference dose was each 
time measured in water phantom using cylindrical ionization chamber 
and renormalized to 1Gy, calibration factors were recalculated. In all 
groups for each chamber the mean, standard deviation and maximum 
deviation between calibration factors were calculated. Changes of 
calibration factors were estimated and observed. 
Results: The median value and standard deviation for the maximum 
difference of calibration factors in 0.5 hour time period was 
0.20%±0.22%, in 2 hours group it was 0.74%±0.30%, once per day it was 
1.13%±1.47% and for once per week 0.65%±1.20%. The largest 
deviations were for once per day calibration group which is correlated 
with beam output changes between next few days. The measurements 
for that group were performed during 2 working weeks.The highest 
deviation was observed between calibration done at Friday and at 
Monday after the weekend. It was observed that for first and last wire 
chambers the deviations were much larger (up to 12%) than for other 
chambers. It occurred for calibrations which were done on 2 similar 
machines and was generated by device holder misalignment. 
Conclusions: The dosimetric system is a good tool for daily real-time 
dose delivery verification. However, it should be carefully calibrated. 
The default calibration time period can be freely adjusted. It does not 
have to be done more frequently. It can be carried out once per 
week. In next step of the study it will be analyzed if once per week 
calibration is sufficient and gives reliable final results of patients 
measurements. Using the device on similar accelerators without dose 
recalibration it is necessary to verify device holder alignment. 
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Purpose/Objective: The purpose of our study is to verify the accuracy 
of Multi-leaf Collimator (MLC) motion during Volumetric Modulated 
Radiation Therapy (VMAT) delivery by use of an in-house program. 
Materials and Methods: We developed an in-house program for 
evaluating the MLC motion by use of the MLC-log during VMAT 
delivery. The program has been built by Visual Basic Ver.6.0 
(Microsoft Corporation, USA). The MLC-log during VMAT delivery was 
exported to our program from the Clinec 21EX linear accelerator 
equipped with the Millenium MLC (Varian, USA) after VMAT delivery. 
As a fundamental evaluation, the basic MLC motion during VMAT 
delivery was verified via our program in comparison with specific 
program for root-mean-square analysis (Dynalog File Viewer (DFV): 
Varian, USA). The collimator angle was fixed at 0 degree. The MLC 
moved from B-side to A-side of carriage box. As clinical evaluations, 
the MLC-logs of some VMAT plans for Head&Neck and prostate 
patients were verified by use of our program and DFV. 
Results: As results of the fundamental evaluation, the maximum error 
of MLC motion with our program was larger than that with DFV 
program. The errors of MLC motion with our program were similar to 
those with DFV program. This means that our program has a potential 
to evaluate MLC-log exactly as well as DFV. The errors became large 
when MLCs were pulled on A-side and/or pushed on B-side. When a 
simple sweeping motion was perfomed, the errors were observed less 
than 0.1 mm. As the results of the clinical evaluation, the maximum 
and mean errors were calculated. For prostate cases, the maximum 
error by use of our program and DFV were 0.90 mm and 0.69 mm, 
respectively. For Head&Neck cases, the maximum errors by use of our 
program and DFV were 0.89 mm and 0.75 mm, respectively. These 
errors were both momentary errors and ineffective for clinical 
prescription dose. In addition, MLC motion error of Head&Neck case 
were larger than those of prostate case As a result of detailed analysis 
in clinical evaluation, almost errors were not continuous but large 
momentary errors. However these errors were acceptable because of 
these ineffective values. 
 
